Published in Ann Neurol on August 01, 2009
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Cerebral amyloid angiopathy in the elderly. Ann Neurol (2011) 2.84
Outcome markers for clinical trials in cerebral amyloid angiopathy. Lancet Neurol (2014) 2.39
Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations. Front Neurol (2014) 1.27
CSF biomarkers for Alzheimer's disease: current utility and potential future use. Neurobiol Aging (2011) 1.16
The overlap between vascular disease and Alzheimer's disease--lessons from pathology. BMC Med (2014) 1.15
Cerebral amyloid angiopathy: emerging concepts. J Stroke (2015) 1.14
Biomarkers in translational research of Alzheimer's disease. Neuropharmacology (2010) 1.11
Interaction between sleep-disordered breathing and apolipoprotein E genotype on cerebrospinal fluid biomarkers for Alzheimer's disease in cognitively normal elderly individuals. Neurobiol Aging (2013) 1.04
Interest of CSF biomarker analysis in possible cerebral amyloid angiopathy cases defined by the modified Boston criteria. J Neurol (2012) 0.93
New therapeutic approaches for Alzheimer's disease and cerebral amyloid angiopathy. Front Aging Neurosci (2014) 0.89
Stroke prevention in atrial fibrillation in older adults: existing knowledge gaps and areas for innovation: a summary of an American Federation for Aging research seminar. J Am Geriatr Soc (2013) 0.88
Dissociated amyloid-beta antibody levels as a serum biomarker for the progression of Alzheimer's disease: a population-based study. Exp Gerontol (2009) 0.88
Biomarkers predicting Alzheimer's disease in cognitively normal aging. J Clin Neurol (2011) 0.84
Cerebral amyloid angiopathy-related atraumatic convexal subarachnoid hemorrhage: an ARIA before the tsunami. J Cereb Blood Flow Metab (2015) 0.82
Dissecting IWG-2 typical and atypical Alzheimer's disease: insights from cerebrospinal fluid analysis. J Neurol (2015) 0.81
Advances in our Understanding of the Pathophysiology, Detection and Management of Cerebral Amyloid Angiopathy. Eur Neurol Rev (2012) 0.81
Cerebral amyloid angiopathy increases susceptibility to infarction after focal cerebral ischemia in Tg2576 mice. Stroke (2014) 0.80
Cerebrospinal fluid profiles with increasing number of cerebral microbleeds in a continuum of cognitive impairment. J Cereb Blood Flow Metab (2015) 0.79
The potential of pathological protein fragmentation in blood-based biomarker development for dementia - with emphasis on Alzheimer's disease. Front Neurol (2015) 0.79
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer's disease. Alzheimers Res Ther (2015) 0.79
Predicting cerebral amyloid angiopathy-related intracerebral hemorrhages and other cerebrovascular disorders in Alzheimer's disease. Front Neurol (2012) 0.79
Cerebral microbleeds topography and cerebrospinal fluid biomarkers in cognitive impairment. J Cereb Blood Flow Metab (2016) 0.79
Corticosteroid therapy in a patient with cerebral amyloid angiopathy-related inflammation. J Neuroinflammation (2013) 0.78
Cerebral white matter lesions - associations with Aβ isoforms and amyloid PET. Sci Rep (2016) 0.77
Florbetapir-PET to diagnose cerebral amyloid angiopathy: A prospective study. Neurology (2016) 0.75
β-Amyloid in CSF: Biomarker for preclinical cerebral amyloid angiopathy. Neurology (2016) 0.75
Pseudotumoral presentation of cerebral amyloid angiopathy-related inflammation. Neurology (2016) 0.75
Thrombolysis-related Multiple Lobar Hemorrhaging in Cerebral Amyloid Angiopathy with Extensive Strictly Lobar Cerebral Microbleeding. Intern Med (2017) 0.75
Cerebrospinal fluid tau/beta-amyloid(42) ratio as a prediction of cognitive decline in nondemented older adults. Arch Neurol (2007) 10.75
Clinical diagnosis of cerebral amyloid angiopathy: validation of the Boston criteria. Neurology (2001) 6.42
Visualization of A beta 42(43) and A beta 40 in senile plaques with end-specific A beta monoclonals: evidence that an initially deposited species is A beta 42(43). Neuron (1994) 6.41
Mutation of the Alzheimer's disease amyloid gene in hereditary cerebral hemorrhage, Dutch type. Science (1990) 4.71
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Novel amyloid precursor protein mutation in an Iowa family with dementia and severe cerebral amyloid angiopathy. Ann Neurol (2001) 3.46
Perivascular drainage of amyloid-beta peptides from the brain and its failure in cerebral amyloid angiopathy and Alzheimer's disease. Brain Pathol (2008) 2.90
Early-onset and robust cerebral microvascular accumulation of amyloid beta-protein in transgenic mice expressing low levels of a vasculotropic Dutch/Iowa mutant form of amyloid beta-protein precursor. J Biol Chem (2004) 2.45
Abeta-degrading enzymes in Alzheimer's disease. Brain Pathol (2008) 2.26
Amyloid angiopathy-related vascular cognitive impairment. Stroke (2004) 2.21
Microbleed topography, leukoaraiosis, and cognition in probable Alzheimer disease from the Sunnybrook dementia study. Arch Neurol (2008) 2.03
Peptide compositions of the cerebrovascular and senile plaque core amyloid deposits of Alzheimer's disease. Arch Biochem Biophys (1993) 1.90
Diagnostic accuracy of ELISA and xMAP technology for analysis of amyloid beta(42) and tau proteins. Clin Chem (2007) 1.88
Cerebral amyloid angiopathy: the vascular pathology and complications. J Neuropathol Exp Neurol (1986) 1.50
Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels. J Neuropathol Exp Neurol (1998) 1.47
Impaired visual evoked flow velocity response in cerebral amyloid angiopathy. Neurology (2008) 1.42
Brain parenchymal and microvascular amyloid in Alzheimer's disease. Brain Pathol (1996) 1.26
Current state and future directions of neurochemical biomarkers for Alzheimer's disease. Clin Chem Lab Med (2007) 1.24
Hereditary cerebral hemorrhage with amyloidosis (Dutch): a model for congophilic plaque formation without neurofibrillary pathology. Acta Neuropathol (1994) 0.89
Vascular contributions to cognitive impairment and dementia: a statement for healthcare professionals from the american heart association/american stroke association. Stroke (2011) 10.11
Variants conferring risk of atrial fibrillation on chromosome 4q25. Nature (2007) 8.03
Frailty in elderly people. Lancet (2013) 7.40
Imaging of amyloid burden and distribution in cerebral amyloid angiopathy. Ann Neurol (2007) 4.11
Molecular imaging with Pittsburgh Compound B confirmed at autopsy: a case report. Arch Neurol (2007) 3.83
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study. Lancet Neurol (2009) 3.65
The effect of warfarin and intensity of anticoagulation on outcome of intracerebral hemorrhage. Arch Intern Med (2004) 3.63
Cardiac-resynchronization therapy in heart failure with narrow QRS complexes. N Engl J Med (2007) 3.61
Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke (2014) 3.48
Cost-effectiveness of using pharmacogenetic information in warfarin dosing for patients with nonvalvular atrial fibrillation. Ann Intern Med (2009) 3.44
Can patients be anticoagulated after intracerebral hemorrhage? A decision analysis. Stroke (2003) 3.12
Advanced age, anticoagulation intensity, and risk for intracranial hemorrhage among patients taking warfarin for atrial fibrillation. Ann Intern Med (2004) 3.06
Amyloid-related imaging abnormalities in amyloid-modifying therapeutic trials: recommendations from the Alzheimer's Association Research Roundtable Workgroup. Alzheimers Dement (2011) 3.05
Characterization of amyloid deposition in the APPswe/PS1dE9 mouse model of Alzheimer disease. Neurobiol Dis (2006) 2.96
Spatial clustering of hemorrhages in probable cerebral amyloid angiopathy. Ann Neurol (2005) 2.85
Cerebral amyloid angiopathy in the elderly. Ann Neurol (2011) 2.84
Prediction of functional outcome in patients with primary intracerebral hemorrhage: the FUNC score. Stroke (2008) 2.72
Disconnection of the ascending arousal system in traumatic coma. J Neuropathol Exp Neurol (2013) 2.38
Variants at APOE influence risk of deep and lobar intracerebral hemorrhage. Ann Neurol (2010) 2.31
Cerebral microinfarcts: the invisible lesions. Lancet Neurol (2012) 2.31
Anti-amyloid β autoantibodies in cerebral amyloid angiopathy-related inflammation: implications for amyloid-modifying therapies. Ann Neurol (2013) 2.29
Confounding by indication in retrospective studies of intracerebral hemorrhage: antiepileptic treatment and mortality. Neurocrit Care (2012) 2.25
Moving the tipping point: the decision to anticoagulate patients with atrial fibrillation. Circ Cardiovasc Qual Outcomes (2010) 2.17
Nonexcitatory, cardiac contractility modulation electrical impulses: feasibility study for advanced heart failure in patients with normal QRS duration. Heart Rhythm (2006) 2.13
Spatial distribution of white-matter hyperintensities in Alzheimer disease, cerebral amyloid angiopathy, and healthy aging. Stroke (2008) 2.12
Clinical manifestations of cerebral amyloid angiopathy-related inflammation. Ann Neurol (2004) 1.95
The cerebral beta-amyloid angiopathies: hereditary and sporadic. Brain Pathol (2006) 1.91
Independent susceptibility markers for atrial fibrillation on chromosome 4q25. Circulation (2010) 1.90
Apolipoprotein E genotype predicts hematoma expansion in lobar intracerebral hemorrhage. Stroke (2012) 1.89
Beta-amyloid, blood vessels, and brain function. Stroke (2009) 1.89
Diagnostic accuracy of ELISA and xMAP technology for analysis of amyloid beta(42) and tau proteins. Clin Chem (2007) 1.88
Estimating cerebral microinfarct burden from autopsy samples. Neurology (2013) 1.87
Cerebrospinal fluid amyloid beta42/phosphorylated tau ratio discriminates between Alzheimer's disease and vascular dementia. J Gerontol A Biol Sci Med Sci (2006) 1.85
Cerebral amyloid angiopathy: a systematic review. J Clin Neurol (2011) 1.77
REEP1 mutation spectrum and genotype/phenotype correlation in hereditary spastic paraplegia type 31. Brain (2008) 1.77
Detection of isolated cerebrovascular beta-amyloid with Pittsburgh compound B. Ann Neurol (2008) 1.74
Peripheral nerve involvement in spinocerebellar ataxias. Arch Neurol (2004) 1.72
The effect of survival bias on case-control genetic association studies of highly lethal diseases. Circ Cardiovasc Genet (2011) 1.71
Performance of the St. Jude Medical Riata leads. Heart Rhythm (2008) 1.71
COL4A1 mutations in patients with sporadic late-onset intracerebral hemorrhage. Ann Neurol (2012) 1.62
Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch Neurol (2008) 1.60
Statin use following intracerebral hemorrhage: a decision analysis. Arch Neurol (2011) 1.59
Acute respiratory distress syndrome after spontaneous intracerebral hemorrhage*. Crit Care Med (2013) 1.58
Lack of replication in polymorphisms reported to be associated with atrial fibrillation. Heart Rhythm (2010) 1.58
Age-dependent cerebrovascular dysfunction in a transgenic mouse model of cerebral amyloid angiopathy. Brain (2007) 1.55
Should anticoagulation be resumed after intracerebral hemorrhage? Cleve Clin J Med (2010) 1.53
Cerebral autoregulation in stroke: a review of transcranial Doppler studies. Stroke (2010) 1.51
Spatial relation between microbleeds and amyloid deposits in amyloid angiopathy. Ann Neurol (2010) 1.50
Access to diagnostic evaluation and treatment for dementia in Europe. Int J Geriatr Psychiatry (2007) 1.49
Near infrared spectroscopy for the detection of desaturations in vulnerable ischemic brain tissue: a pilot study at the stroke unit bedside. Stroke (2011) 1.47
APOE genotype and extent of bleeding and outcome in lobar intracerebral haemorrhage: a genetic association study. Lancet Neurol (2011) 1.47
Descriptive analysis of the Boston criteria applied to a Dutch-type cerebral amyloid angiopathy population. Stroke (2009) 1.46
COL4A2 mutations impair COL4A1 and COL4A2 secretion and cause hemorrhagic stroke. Am J Hum Genet (2011) 1.38
Neuroanatomic connectivity of the human ascending arousal system critical to consciousness and its disorders. J Neuropathol Exp Neurol (2012) 1.38
Validation of intracranial area as a surrogate measure of intracranial volume when using clinical MRI. J Neuroimaging (2007) 1.33
Topography of dilated perivascular spaces in subjects from a memory clinic cohort. Neurology (2013) 1.33
Hematoma expansion following acute intracerebral hemorrhage. Cerebrovasc Dis (2013) 1.30
Predicting sites of new hemorrhage with amyloid imaging in cerebral amyloid angiopathy. Neurology (2012) 1.29
Functional magnetic resonance imaging detection of vascular reactivity in cerebral amyloid angiopathy. Ann Neurol (2012) 1.29
Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study. Ann Neurol (2013) 1.27
Effect of statins on intracerebral hemorrhage outcome and recurrence. Stroke (2008) 1.26
Age at onset variance analysis in spinocerebellar ataxias: a study in a Dutch-French cohort. Ann Neurol (2005) 1.26
Kinetics of cerebral amyloid angiopathy progression in a transgenic mouse model of Alzheimer disease. J Neurosci (2006) 1.24
Current state and future directions of neurochemical biomarkers for Alzheimer's disease. Clin Chem Lab Med (2007) 1.24
MRI markers of small vessel disease in lobar and deep hemispheric intracerebral hemorrhage. Stroke (2010) 1.23
Apolipoprotein E genotype is associated with CT angiography spot sign in lobar intracerebral hemorrhage. Stroke (2012) 1.19
Tissue microstructural changes are independently associated with cognitive impairment in cerebral amyloid angiopathy. Stroke (2008) 1.19
Anemia and hematoma volume in acute intracerebral hemorrhage. Crit Care Med (2009) 1.17
Interstitial fluid drainage is impaired in ischemic stroke and Alzheimer's disease mouse models. Acta Neuropathol (2013) 1.15
CTA spot sign predicts hematoma expansion in patients with delayed presentation after intracerebral hemorrhage. Neurocrit Care (2012) 1.14
What is a genetic cause? The example of Alzheimer's Disease. Med Health Care Philos (2006) 1.12
Cerebrovascular lesions induce transient β-amyloid deposition. Brain (2011) 1.10
The genetic architecture of intracerebral hemorrhage. Stroke (2008) 1.08
Matrix metalloproteinase inhibition reduces oxidative stress associated with cerebral amyloid angiopathy in vivo in transgenic mice. J Neurochem (2009) 1.08
Antibody-mediated clearance of amyloid-beta peptide from cerebral amyloid angiopathy revealed by quantitative in vivo imaging. J Neurosci (2007) 1.07
The Mediterranean diet as prevention strategy for dementia as a multicausal geriatric syndrome. Am J Clin Nutr (2013) 1.07
MR imaging and proton MR spectroscopic studies in Sjögren-Larsson syndrome: characterization of the leukoencephalopathy. AJNR Am J Neuroradiol (2004) 1.05
White matter alterations in cerebral amyloid angiopathy measured by diffusion tensor imaging. Stroke (2006) 1.05
Dynamic single-section CT demonstrates reduced cerebral blood flow in acute intracerebral hemorrhage. Cerebrovasc Dis (2002) 1.04
Characteristic distributions of intracerebral hemorrhage-associated diffusion-weighted lesions. Neurology (2012) 1.03
CT angiography for intracerebral hemorrhage does not increase risk of acute nephropathy. Stroke (2009) 1.02
Heritability estimates identify a substantial genetic contribution to risk and outcome of intracerebral hemorrhage. Stroke (2013) 1.02
Principal-component analysis for assessment of population stratification in mitochondrial medical genetics. Am J Hum Genet (2010) 1.02
Distribution of white matter hyperintensity in cerebral hemorrhage and healthy aging. J Neurol (2011) 1.01
Spot sign score predicts rapid bleeding in spontaneous intracerebral hemorrhage. Emerg Radiol (2012) 1.01
Packed red blood cell transfusion and decreased mortality in intracerebral hemorrhage. Neurosurgery (2011) 1.01
Red meets white: do microbleeds link hemorrhagic and ischemic cerebrovascular disease? Neurology (2009) 1.00
Embrace, a model for integrated elderly care: study protocol of a randomized controlled trial on the effectiveness regarding patient outcomes, service use, costs, and quality of care. BMC Geriatr (2013) 0.99
Progression of cerebral amyloid angiopathy in transgenic mouse models of Alzheimer disease. J Neuropathol Exp Neurol (2005) 0.99
Falls in spinocerebellar ataxias: Results of the EuroSCA Fall Study. Cerebellum (2010) 0.98
Body mass index and etiology of intracerebral hemorrhage. Stroke (2011) 0.98
Comparison of hematoma shape and volume estimates in warfarin versus non-warfarin-related intracerebral hemorrhage. Neurocrit Care (2010) 0.98
Modeling intracerebral hemorrhage growth and response to anticoagulation. PLoS One (2012) 0.98
Falls in degenerative cerebellar ataxias. Mov Disord (2005) 0.98
Common mitochondrial sequence variants in ischemic stroke. Ann Neurol (2010) 0.97
Hemorrhagic stroke. Neuroimaging Clin N Am (2005) 0.97
Burden of risk alleles for hypertension increases risk of intracerebral hemorrhage. Stroke (2012) 0.96